Bruker (BRKR)

• Market cap: $6.08B
• 1 day: 0.55%
• 5 days: 6.57%
• 1 month: -4.02%
• 3 months: -29.72%
• 6 months: -31.53%
• Year to date: -31.88%
• 1 year: -48.65%
• 5 years: 1.88%
• 10 years: 111.29%
• Sector: Healthcare
• Industry: Medical Devices

About: Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.

Employees: 11,396

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

40% more funds holding in top 10

Funds holding in top 10: 5 [Q3] → 7 (+2) [Q4]

28% more repeat investments, than reductions

Existing positions increased: 145 | Existing positions reduced: 113

4.06% more ownership

Funds ownership: 76.8% [Q3] → 80.85% (+4.06%) [Q4]

8% more first-time investments, than exits

New positions opened: 68 | Existing positions closed: 63

0% more funds holding

Funds holding: 363 [Q3] → 363 (+0) [Q4]

9% less capital invested

Capital invested by funds: $7.93B [Q3] → $7.19B (-$745M) [Q4]

65% less call options, than puts

Call options by funds: $32.8M | Put options by funds: $93M

Research analyst outlook

4 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $50 25% upside
• Avg. target: $54 35% upside
• High target: $60 50% upside

4 analyst ratings

• positive: 3 75%
• neutral: 1 25%
• negative: 0 0%

Wells Fargo Brandon Couillard 8% 1-year accuracy 2 / 25 met price target	50% upside $60	Overweight Maintained	17 Apr 2025
Barclays Luke Sergott 36% 1-year accuracy 21 / 59 met price target	25% upside $50	Overweight Maintained	10 Apr 2025
Citigroup Patrick Donnelly 27% 1-year accuracy 8 / 30 met price target	25% upside $50	Buy Maintained	7 Apr 2025
Stifel Daniel Arias 15% 1-year accuracy 3 / 20 met price target	42% upside $57	Hold Maintained	14 Feb 2025